Matches in Wikidata for { <http://www.wikidata.org/entity/Q37092351> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q37092351 description "article científic" @default.
- Q37092351 description "article scientifique" @default.
- Q37092351 description "articolo scientifico" @default.
- Q37092351 description "artigo científico" @default.
- Q37092351 description "artículu científicu espublizáu en xineru de 2008" @default.
- Q37092351 description "bilimsel makale" @default.
- Q37092351 description "scientific article published on 31 January 2008" @default.
- Q37092351 description "vedecký článok" @default.
- Q37092351 description "vetenskaplig artikel" @default.
- Q37092351 description "videnskabelig artikel" @default.
- Q37092351 description "vědecký článek" @default.
- Q37092351 description "wetenschappelijk artikel" @default.
- Q37092351 description "wissenschaftlicher Artikel" @default.
- Q37092351 description "наукова стаття, опублікована в січні 2008" @default.
- Q37092351 description "научни чланак" @default.
- Q37092351 description "مقالة علمية نشرت في 31 يناير 2008" @default.
- Q37092351 name "Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues" @default.
- Q37092351 name "Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues" @default.
- Q37092351 type Item @default.
- Q37092351 label "Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues" @default.
- Q37092351 label "Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues" @default.
- Q37092351 prefLabel "Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues" @default.
- Q37092351 prefLabel "Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues" @default.
- Q37092351 P1433 Q37092351-056C90EC-D24C-46DC-B808-0AB2B0132523 @default.
- Q37092351 P1476 Q37092351-5D179D9C-0DA0-4201-ABC1-BEDC3576EA99 @default.
- Q37092351 P2093 Q37092351-02FBAF7F-F218-4EB5-AD06-78CECE7A776F @default.
- Q37092351 P2093 Q37092351-14248EB5-7595-43E8-B853-C66325C12300 @default.
- Q37092351 P2093 Q37092351-512F6307-51F6-4F7A-B7AE-3CF3105CC0F4 @default.
- Q37092351 P2093 Q37092351-E087EE03-0769-4E3B-9140-509D55A74B78 @default.
- Q37092351 P304 Q37092351-D72F2EF5-84AC-4A7B-9A86-612472D1085A @default.
- Q37092351 P31 Q37092351-4DF5F000-3F46-4DDF-97C5-933E8FA3F9D6 @default.
- Q37092351 P31 Q37092351-f009bf37-4457-4fc7-bc61-6020a83e8cfa @default.
- Q37092351 P356 Q37092351-C0A62B46-53BA-4DC3-B567-A17411F48EA7 @default.
- Q37092351 P407 Q37092351-1480695F-9EF1-4DF0-9C33-B86AE26DAD4C @default.
- Q37092351 P433 Q37092351-F63104FC-E1AC-4C11-88F4-333C82A652B9 @default.
- Q37092351 P478 Q37092351-31ADF004-1ED3-45A0-8369-CE7CB2FF429A @default.
- Q37092351 P50 Q37092351-234A0A49-E1A8-477B-9217-CA34666FB5A8 @default.
- Q37092351 P50 Q37092351-531B824E-23AB-4150-87FE-7A37C26E0B6A @default.
- Q37092351 P50 Q37092351-64B78ECF-CD10-48CA-ABDF-55AF3D724726 @default.
- Q37092351 P50 Q37092351-73A0482F-38CA-4584-8EEA-F22AC5F97185 @default.
- Q37092351 P50 Q37092351-A276CDD2-9813-4E84-86BC-C566701DB54D @default.
- Q37092351 P50 Q37092351-C447E0C9-30A8-468F-8E68-3E89FF090C76 @default.
- Q37092351 P50 Q37092351-E8E49D83-A22A-40F2-92DC-D3D75CA2B817 @default.
- Q37092351 P577 Q37092351-D6D05A42-71D2-41F6-9D8C-195F8E3A8AA8 @default.
- Q37092351 P5875 Q37092351-4422AB4D-D2AA-4D90-B2C1-FB466F6A1778 @default.
- Q37092351 P698 Q37092351-D981C8B2-21E3-4F66-8D1F-3E0D35DBA98B @default.
- Q37092351 P921 Q37092351-E2D7E8CD-7965-4F68-8B09-096780F01552 @default.
- Q37092351 P356 J.AHJ.2007.12.005 @default.
- Q37092351 P698 18294475 @default.
- Q37092351 P1433 Q2227156 @default.
- Q37092351 P1476 "Clinical and research issues regarding chronic advanced coronary artery disease part II: Trial design, outcomes, and regulatory issues" @default.
- Q37092351 P2093 "Bernard R Chaitman" @default.
- Q37092351 P2093 "E Marc Jolicoeur" @default.
- Q37092351 P2093 "Timothy D Henry" @default.
- Q37092351 P2093 "Working Group Members" @default.
- Q37092351 P304 "435-444" @default.
- Q37092351 P31 Q13442814 @default.
- Q37092351 P31 Q7318358 @default.
- Q37092351 P356 "10.1016/J.AHJ.2007.12.005" @default.
- Q37092351 P407 Q1860 @default.
- Q37092351 P433 "3" @default.
- Q37092351 P478 "155" @default.
- Q37092351 P50 Q110562052 @default.
- Q37092351 P50 Q114291629 @default.
- Q37092351 P50 Q19281782 @default.
- Q37092351 P50 Q38590165 @default.
- Q37092351 P50 Q60697402 @default.
- Q37092351 P50 Q62050240 @default.
- Q37092351 P50 Q82174061 @default.
- Q37092351 P577 "2008-01-31T00:00:00Z" @default.
- Q37092351 P5875 "5558739" @default.
- Q37092351 P698 "18294475" @default.
- Q37092351 P921 Q844935 @default.